Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: Identification by a novel enzyme immunoassay
M. Kakutani et al., Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: Identification by a novel enzyme immunoassay, BIOC BIOP R, 282(1), 2001, pp. 180-185
Citations number
25
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LOX-1 (lectin-like oxidized LDL receptor) is a newly identified cell surfac
e receptor for oxidized LDL mainly expressed in endothelial cells. Recombin
ant soluble LOX-1(LOX-Fc) was generated by fusing the extracellular domain
of LOX-1 with the Fc portion of IgG. A novel sandwich enzyme immunoassay sp
ecific for LOX-1 ligand is designed, using LOX-Fc and anti-apoB antibody. T
his immunoassay was used to determine LOX-1 ligand activity in normal and W
atanabe heritable hyperlipidemic (WHHL) rabbit plasma. LOX-Fc was further a
pplied for staining of atherosclerotic lesions of WHHL rabbits. LOX-I ligan
d levels were significantly elevated in the plasma of hyperlipidemic rabbit
s compared with controls. Furthermore, LOX-1 ligand activity was detected i
n the atherosclerotic lesions in situ. These results support the potential
roles of LOX-1 interacting with its ligand in the pathogenesis of atheroscl
erosis, which is enhanced in hyperlipidemia. (C) 2001 Academic Press.